Neobiotic (Neomycin)

Neomycin, the active ingredient in Neobiotic, is an aminoglycoside antibiotic presented as a topical preparation for skin application. It treats bacterial skin infections and is used on minor cuts, abrasions, and burns.

GNH USA supplies Neobiotic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neomycin is an aminoglycoside antibiotic used for bacterial skin conditions and wound care. - Impetigo: reduces bacterial load and promotes healing of superficial skin infection. - Minor cuts and abrasions: prevents infection and aids recovery of small traumatic lesions. - First‑degree burns: limits bacterial colonisation and supports re‑epithelialisation.

Neomycin may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Skin irritation: redness or mild discomfort at the application site. - Itching: localized pruritus following use. - Burning sensation: transient warmth or stinging. - Dryness: mild desiccation of the treated skin. - Erythema: mild redness without infection. - Peeling: superficial flaking of skin.

Serious or Rare Side Effects: - Allergic contact dermatitis: severe rash, swelling, or vesicles. - Anaphylaxis: rare systemic allergic reaction requiring emergency care. - Systemic nephrotoxicity: unlikely but possible with extensive use. - Ototoxicity: rare hearing changes if absorbed in large amounts. - Severe skin necrosis: very rare tissue damage. - Hyperpigmentation: persistent darkening of treated area.

Neomycin should be used with caution and according to professional guidance. - Allergy assessment: avoid if known hypersensitivity to neomycin or other aminoglycosides. - Pregnancy: use only if potential benefit justifies potential risk to the fetus. - Breastfeeding: limited data; consider risk‑benefit before use. - Application area: limit to small skin surfaces; do not apply to eyes, ears, or mucous membranes. - Duration of therapy: do not exceed the prescribed period, typically no longer than 7 days. - Store at below 25°C: keep in the original container, protect from moisture and light.

Neomycin may interact with other medicines, affecting safety or efficacy.

Major Interactions (Avoid): - Systemic aminoglycosides: concurrent use can increase risk of nephrotoxicity and ototoxicity. - Loop diuretics: may potentiate ototoxic effects when combined. - Neuromuscular blocking agents: risk of enhanced neuromuscular blockade.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may reduce antibacterial efficacy of neomycin. - Other topical antibiotics: increased risk of local irritation or additive toxicity.